2,639
Views
0
CrossRef citations to date
0
Altmetric
Research Article

MTHFR A1298C polymorphism: a predictor of reduced risk of preeclampsia in Punjab, Pakistan

ORCID Icon, , &
Article: 2187621 | Received 28 Sep 2022, Accepted 01 Mar 2023, Published online: 15 Mar 2023

References

  • George EM, Granger JP. Recent insights into the pathophysiology of preeclampsia. Expert Rev Obstet Gynecol. 2010 Sep 1;5(5):557–10.
  • Osungbade KO, Ige OK. public health perspectives of preeclampsia in developing countries: implication for health system strengthening. J Pregnancy. 2011;2011:e481095. Apr 4; 2011. DOI:10.1155/2011/481095
  • Unicef. Trends in maternal mortality: 1990 to 2013. Geneva: World Health Organization; 2014.
  • Goldenberg RL, Rouse DJ. Prevention of premature birth. N Engl J Med. 1998 Jul 30;339(5):313–320.
  • Mou AD, Barman Z, Hasan M, et al. Prevalence of preeclampsia and the associated risk factors among pregnant women in Bangladesh. Sci Rep. 2021 Oct 29;11(1):21339. DOI:10.1038/s41598-021-00839-w
  • Kovo M, Schreiber L, Ben-Haroush A, et al. The placental component in early-onset and late-onset preeclampsia in relation to fetal growth restriction. Prenat Diagn. 2012;32(7):632–637.
  • Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod. 2003 Jul;69(1):1–7.
  • Brosens I. A study of the spiral arteries of the decidua basalis in normotensive and hypertensive pregnancies. J Obstet Gynaecol Br Commonw. 1964 Apr;71(2):222–230.
  • Sibai B, Lindheimer M, Hauth J, et al. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. New Engl J Med. 1998 Oct 1;339(10):667–671. DOI:10.1056/NEJM199809033391004
  • Shiozaki A, Matsuda Y, Satoh S, et al. Impact of fetal sex in pregnancy-induced hypertension and preeclampsia in Japan. J Reprod Immunol. 2011;89(2):133–139.
  • Yang J, Pearl M, DeLorenze GN, et al. Racial-ethnic differences in midtrimester maternal serum levels of angiogenic and antiangiogenic factors. Am J Clin Exp Obstet Gynecol. 2016;215(3): 359-e1. doi:10.1016/j.ajog.2016.04.002.
  • Shamsi U, Hatcher J, Shamsi A, et al. A multicentre matched case control study of risk factors for preeclampsia in healthy women in Pakistan. BMC Women’s Health. 2010 Dec;10(1):1–7.
  • Ahmed T, Ali S, Aliaga A, et al. Pakistan demographic and health survey 1990/91. Pakistan: National Institute of Population Studies Islamabad; 1992.
  • Skjaerven R, Wilcox AJ, Lie RT. The interval between pregnancies and the risk of preeclampsia. N Engl J Med. 2002;346(1):33–38.
  • Endeshaw M, Ambaw F, Aragaw A, et al. Effect of maternal nutrition and dietary habits on preeclampsia: a case-control study. Int J Clin Med. 2014 Dec 4;05(21):1405.
  • Esplin MS, Fausett MB, Fraser A, et al. Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med. 2001;344(12):867–872. DOI:10.1056/NEJM200103223441201
  • Leclerc D, Sibani S, Rozen R Molecular biology of methylenetetrahydrofolate reductase (MTHFR) and overview of mutations/polymorphisms [Internet]. Madame Curie Bioscience Database [Internet]. Landes Bioscience; 2013 [cited 2021 Dec 25]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK6561/
  • Canbakan B, Keven K, Tutkak H, et al. Circulating endothelial cells in preeclampsia. J Hum Hypertens. 2007 Jul;21(7):558–563.
  • Kharb S, Aggarwal D, Nanda JB, et al., Evaluation of homocysteine, vitamin B12 and folic acid levels during all the trimesters in pregnant and preeclamptic womens [internet]. Curr Hypertens Rev 2016;12:234–238. Available from: cited 2020 Aug 26 10.2174/1573402112666161010151632.
  • Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet. 1995;10(1):111–113. DOI:10.1038/ng0595-111
  • Der Put Nmj V, Gabreëls F, Stevens EMB, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet. 1998 May;62(5):1044–1051.
  • Khidri FF, Waryah YM, Ali FK, et al. MTHFR and F5 genetic variations have association with preeclampsia in Pakistani patients: a case control study. BMC Med Gene. 2019;20(1):163.
  • Sambrook J, Fritsch EF, Maniatis T Molecular cloning: a laboratory manual. molecular cloning: a laboratory manual [Internet]. 1989 [cited 2021 Apr 6];(Ed. 2). Available from: https://www.cabdirect.org/cabdirect/abstract/19901616061
  • Harmon DL, Woodside JV, Yarnell JWG, et al. The common ‘thermolabile’variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. QJM. 1996;89(8):571–578. DOI:10.1093/qjmed/89.8.571
  • Markan S, Sachdeva M, Sehrawat BS, et al. MTHFR 677 CT/MTHFR 1298 CC genotypes are associated with increased risk of hypertension in Indians. Mol Cell Biochem. 2007;302(1):125–131.
  • Alghasham A, Settin AA, Ali A, et al. Association of MTHFR C677T and A1298C gene polymorphisms with hypertension. Int J Health Sci (Qassim). 2012;6(1):3.
  • Poduri A, Kumari S, Jain S, et al. A case–control study of the association between the MTHFR gene and essential hypertension in Asian Indians. J Hum Hypertens. 2009 Feb;23(2):140–142.
  • Yang B, Liu Y, Li Y, et al. Geographical distribution of MTHFR C677T, A1298C and MTRR A66G gene polymorphisms in China: findings from 15357 adults of han nationality. PLoS ONE. 2013 Mar 5;8(3):e57917. DOI:10.1371/journal.pone.0057917
  • Saraswathy KN, Asghar M, Samtani R, et al. Spectrum of MTHFR gene SNPs C677T and A1298C: a study among 23 population groups of India. Mol Biol Rep. 2012 Apr 1;39(4):5025–5031. DOI:10.1007/s11033-011-1299-8
  • Sabbagh AS, Mahfoud Z, Taher A, et al. High Prevalence of MTHFR gene A1298C polymorphism in Lebanon. Genet Test. 2008 Mar 1;12(1):75–80.
  • Roje S, Chan SY, Kaplan F, et al. Metabolic engineering in yeast demonstrates thatS-Adenosylmethionine controls flux through the methylenetetrahydrofolate reductase reaction in vivo*. J Biol Chem. 2002 Feb 8;277(6):4056–4061. DOI:10.1074/jbc.M110651200
  • Wiemels JL, Smith RN, Taylor GM, et al. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. PNAS. 2001;98(7): 4004–4009.
  • Krajinovic M, Lamothe S, Labuda D, et al. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood. 2004 Jan 1;103(1):252–257. DOI:10.1182/blood-2003-06-1794
  • De Mattia E, Toffoli G. C677T and A1298C MTHFR polymorphisms, a challenge for antifolate and fluoropyrimidine-based therapy personalisation. Eur J Cancer. 2009 May 1;45(8):1333–1351.
  • Zusterzeel PLM, Visser W, Bolm HJ, et al. Methylenetetrahydrofolate reductase polymorphisms in preeclampsia and the hellp syndrome. Hypertens Pregnancy. 2000 Jan 1;19(3):299–307. DOI:10.1081/PRG-100101991
  • Othman G, Badawy AE, Elbaz R, et al. Thrombophilic genes mutations in preeclampsia. Bulletin Egyptian Soc Physiol Sci. 2010;30(2):21–34.
  • Azimi-Nezhad M, Teymoori A, Salmaninejad A, et al. Association of MTHFR C677T polymorphism with preeclampsia in north east of Iran (khorasan province). Fetal Pediatr Pathol. 2019 Aug 26;0(0):1–8.
  • Chedraui P, Salazar-Pousada D, Villao A, et al. Polymorphisms of the methylenetetrahydrofolate reductase gene (C677T and A1298C) in nulliparous women complicated with preeclampsia. Gynecological Endocrinol. 30(5). Internet. 392–396. 2014 Apr 15[cited 2020 Aug 27]; Available from. https://www.tandfonline.com/doi/abs/10.3109/09513590.2014.895807.
  • Salimi S, Saravani M, Yaghmaei M, et al. The early-onset preeclampsia is associated with MTHFR and FVL polymorphisms. Arch Gynecol Obstetrics. 2015;291(6):1303–1312. DOI:10.1007/s00404-014-3561-5
  • Butler S, Young A, Akam EC, et al. Association of methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms with coronary artery disease (CAD) in a North Indian population. Schumacher U, editor. Cogent Med. 2018 Jan 1;5(1):1478477. 10.1080/2331205X.2018.1478477
  • Kamel AM, Moussa HS, Ebid GT et al. Synergistic effect of methyltetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphism as risk modifiers of pediatric acute lymphoblastic leukemia. J Egypt Natl Canc Inst. 2007 Jun;19(2): 96–105.
  • Agarwal R, Light RP. GFR, proteinuria and circadian blood pressure. Nephrol Dialysis Transplantation. 2009;24(8):2400–2406.
  • Belogolovkin V, Eddleman KA, Malone FD, et al. The effect of low body mass index on the development of gestational hypertension and preeclampsia. J Matern Fetal Neonatal Med. 2007 Jan;20(7):509–513.
  • Andraweera PH, Gatford KL, Care AS, et al. Mechanisms linking exposure to preeclampsia in utero and the risk for cardiovascular disease. J Dev Orig Health Dis. 2020 Jun;11(3):235–242.
  • van Guldener C, Nanayakkara PW, Stehouwer CD. Homocysteine and blood pressure. Curr Hypertens Rep. 2003;5(1):26–31.
  • Also-Rallo E, Lopez-Quesada E, Urreizti R, et al. Polymorphisms of genes involved in homocysteine metabolism in preeclampsia and in uncomplicated pregnancies. Eur J Obstet Gynecol Reprod Biol. 2005 May;120(1):45–52.
  • Bdolah Y, Elchalal U, Natanson-Yaron S, et al. Relationship between nulliparity and preeclampsia may be explained by altered circulating soluble fms-like tyrosine kinase 1. Hypertens Pregnancy. 2014 May 1;33(2):250–259. DOI:10.3109/10641955.2013.858745
  • Bezerra PCFM, Leão MD, Queiroz JW, et al. Family history of hypertension as an important risk factor for the development of severe preeclampsia. Acta Obstet Gynecol Scand. 2010 May 1;89(5):612–617. DOI:10.3109/00016341003623720